ReCor Medical today announced it appointed Lara Barghout as president and CEO.
Barghout will succeed Andrew Weiss and will be responsible for leading the Palo Alto, California-based company’s business strategy and organization in a new direction – commercializing ReCor’s Paradise ultrasound renal denervation (uRDN) system that treats hypertension.
“I am honored to lead the extraordinary team at ReCor at an exciting time in the company’s growth,” Barghout said in a news release. “High blood pressure is a leading contributor to cardiovascular disease burden worldwide, resulting in increased patient risk and higher costs to health systems. I look forward to leading our focus to advance uRDN as a treatment for hypertension and the global commercialization of the Paradise uRDN System. We believe our Paradise uRDN technology to be a true game changer in improving hypertension therapy, with the potential to offer a new option for physicians to help improve blood pressure outcomes for their patients on a global scale.”
She has more than 20 years of experience leading global businesses in the medical device industry. She most recently was senior VP and head of advanced therapies at Siemens Healthineers, where she lead the image-guided therapy business in North America. She has also held numerous leadership roles at Terumo Cardiovascular.
“We are delighted to name Ms. Barghout President and CEO of ReCor. She is a highly experienced leader with a track record of commercial success across a range of medical device businesses, coupled with extensive experience in global leadership,” said Noriko Tojo, Executive Director of Record Medical’s parent company Otsuka Holdings. “We are very excited for Ms. Barghout to lead ReCor into its next phase of global growth. Her deep commercial experience and adept leadership make her ideal to build on the technology development and clinical trial successes of the ReCor team, guiding the business to realize its therapeutic and commercial potential. I would like to thank Andy for his outstanding leadership and countless contributions over the past 10 years.”